Fuad El-Hibri Biz

Fuad El-Hibri is the President, Chief Executive Officer and Chairman of the Board of Directors of Emergent Biosolutions, a Maryland-based biotechnology company focused on the development, manufacture and commercialization of immunobiotics. BioWatch: Emergent gets boost from FDA
Emergent is the sole manufacturer of and FDA-licensed anthrax vaccine, BioThrax. Mr. El-Hibri is a member of the Board of Trustees of American University and of the International Biomedical Research Alliance.
Professional Biography

Organization
Position
Status

Emergent BioSolutions Inc.
Chief Executive Officer
Current

The National Health Museum, Inc
President, Chief Executive Officer and Chairman of the Board of Directors of Emergent Biosolutions
Current

Emergent BioSolutions Inc.
President
Current

Emergent BioSolutions Inc.
Chairman of the Board of Directors
Current

American University
Board of Directors
Current

Recent News About Fuad El-Hibri

• Emergent BioSolutions Receives FDA Approval Extending Shelf Life of BioThrax (Anthrax Vaccine Adsorbed) to 4 Years [Business Wire]
• Emergent BioSolutions Receives FDA Approval Extending Shelf Life of BioThrax (Anthrax Vaccine… [Forbes.com]
• UPDATE 1-Emergent gets anthrax vaccine expiry date extension [Reuters]

Related posts:

1. Fuad El-Hibri Yale Health Care Advisory Board Mr. Fuad El-Hibri has served as chief executive officer and...
2. Board expands with Election of Fuad El-Hibri NHM Chairman Louis Sullivan, MD, has announced the election of...
3. Ernst & Young’s Entrepreneur of the Year Fuad El-Hibri chairman and chief executive officer, Mr. Fuad El-Hibri, is a...

Related posts brought to you by Yet Another Related Posts Plugin.